Johnson & Johnson stock holds steady on a broad healthcare profile

Johnson & Johnson stock reflects a diversified healthcare group with a wide consumer, pharma and medtech footprint.

Johnson & Johnson (ISIN US4781601046) is a diversified healthcare company with operations spanning innovative medicine, medtech and consumer health, and its shares trade on the New York Stock Exchange as a blue-chip US stock.

Business model

The company is best known for combining prescription medicines, medical devices and consumer products under one corporate umbrella. That mix gives Johnson & Johnson exposure to multiple demand drivers across healthcare rather than a single product cycle.

Market context

For investors, that structure matters because it can soften reliance on any one franchise and tie the stock more closely to broad healthcare spending, drug pipelines and device adoption. The company is also a member of the Dow Jones Industrial Average, which reinforces its status as a core US large-cap name.

Consumer brands

Its consumer health heritage includes brands that are widely recognized in household and personal-care categories, even though the company now emphasizes pharmaceuticals and medical technology more heavily.

Stock context

Johnson & Johnson stock trades on the NYSE in US dollars. The latest market price, market cap and earnings schedule are not included here.

Fact box

• Company: Johnson & Johnson
• ISIN: US4781601046
• Ticker: JNJ
• Exchange: NYSE
• Sector / Industry: Healthcare / Pharmaceuticals, Biotechnology & Life Sciences
• Index membership: Dow Jones Industrial Average